Meeder Asset Management Inc Sangamo Therapeutics, Inc Transaction History

Meeder Asset Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$9.38 - $12.48 $36,113 - $48,048	-3,850 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $15,692 - $29,894	2,527 Added 191.01%	3,850 $34,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $2,974 - $5,212	589 Added 80.25%	1,323 $8,000
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $1,686 - $2,457	210 Added 40.08%	734 $6,000
Q3 2019 Oct 17, 2019	BUY	$9.05 - $12.22 $4,742 - $6,403	524 New	524 $5,000
Q2 2019 Aug 05, 2019	SELL	$8.75 - $13.03 $1,758 - $2,619	-201 Closed	0 $0
Q1 2019 Apr 16, 2019	SELL	$7.72 - $12.81 $4,145 - $6,878	-537 Reduced 72.76%	201 $2,000
Q4 2018 Jan 17, 2019	BUY	$9.51 - $16.6 $5,582 - $9,744	587 Added 388.74%	738 $8,000
Q3 2018 Nov 02, 2018	SELL	$13.05 - $19.05 $6,642 - $9,696	-509 Reduced 77.12%	151 $0
Q2 2018 Jul 24, 2018	SELL	$13.9 - $19.8 $10,689 - $15,226	-769 Reduced 53.81%	660 $0
Q1 2018 May 03, 2018	BUY	$16.7 - $26.35 $9,285 - $14,650	556 Added 63.69%	1,429 $27,000
Q4 2017 Feb 02, 2018	BUY	$11.6 - $17.35 $6,844 - $10,236	590 Added 208.48%	873 $14,000
Q3 2017 Oct 20, 2017	BUY	$8.4 - $15.0 $2,377 - $4,245	283	283 $4,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $362M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.